PharmaNutra
€70.50Change from previous close: −0.98%Absolute change: −€0.70
At a glance
- Revenue growth
- +13.83%
- 2025 vs 2024
- Net income growth
- +20.44%
- 2025 vs 2024
- Net margin
- 15.0%
- 2024: 14.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.8 | 2.0 | 11.6 | 8.3 | -2.4 | — |
| Depreciation and amortization | 0.8 | 0.9 | 0.7 | 1.1 | 0.8 | — |
| Capital expenditure | -1.4 | -1.0 | -0.9 | -0.8 | -0.7 | — |
| Investing cash flow | 1.1 | -2.0 | -1.6 | -0.9 | -0.8 | — |
| Financing cash flow | -12.2 | 2.6 | -6.0 | -1.7 | -11.7 | — |
| Dividends paid | — | — | 0.0 | 0.0 | — | — |
| Share repurchases | — | 0.0 | -0.7 | 0.0 | -0.4 | -0.2 |
| Net change in cash | -13.9 | 2.6 | 3.9 | 5.7 | -14.9 | — |
| Free cash flow | -4.2 | 1.0 | 10.7 | 7.5 | -3.2 | — |